Home
About
Overview
Sharing Data
ORCID
Help
History (98)
Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma.
Phase I Study of the Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (TAK-924/MLN4924) in Patients with Advanced Solid Tumors.
PTEN and LKB1 are differentially required in Gli1-expressing mesenchymal cells to suppress gastrointestinal polyposis.
Gut microbiome functionality might be associated with exercise tolerance and recurrence of resected early-stage lung cancer patients.
Molecular targets for radiation oncology in prostate cancer.
See All 98 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Molecular targets for radiation oncology in prostate cancer.
Wang T, Languino LR, Lian J, Stein G, Blute M, Fitzgerald TJ. Molecular targets for radiation oncology in prostate cancer. Front Oncol. 2011; 1:17.
View in:
PubMed
authors with profiles
Tao Wang PhD
Jane B Lian PhD
Thomas J FitzGerald MD